摘要
目的通过观察硫代磷酸化修饰的Ki-67抗原反义寡核苷酸(antisenseoligodeoxyribonucleoti-de,ASODN)抑制Ki-67抗原表达,从而抑制HEPG-7402细胞体外增殖,为今后肝癌的基因治疗提供新的手段。方法将Ki-67反义寡核苷酸(ASODN)作用于HEPG-7402细胞,MTT比色法测细胞增殖活性;免疫细胞化学(ImmunocellulerchemistryICC)方法检测Ki-67标记指数(LabelingindexLI)、RT-PCR方法观察Ki-67mRNA水平的改变。结果Ki-67ASODN作用组HEPG-7402细胞增殖受到明显抑制;Ki-67标记指数(LI)下降,Ki-67mRNA合成减少。结论针对Ki-67的反义寡核苷酸能抑制人肝癌细胞株的体外生长。
Objective To investigate phosphorothioated antisense oligodeoxynucleotide (ASODN) target Ki-67 decreasing the antigene's expression and inhibiting proliferation of HEPG-7402 cell in vitro. It will show us a new method to cure hepatocellular carcinoma by genetherapy in the future. Methods We treat HEPG-7402 cells with ASODN and observe changes of cell's proliferation by the way of MTT. ICC technique was used to find the change of cell's Ki-67 labeling index (LI). RT-PCR method was used for detecting Ki-67 mRNA's change. Results HEPG-7402 cell's growth was inhibited, Ki-67 labeling index was decreased, and the expression of Ki-67 mRNA was decreased in ASODN group. Conclusion ASODN target against Ki-67 can inhibit the proliferation of human hepatocellular carcinoma cell HEPG-7402 in vitro.
出处
《肿瘤防治研究》
CAS
CSCD
北大核心
2006年第12期862-864,共3页
Cancer Research on Prevention and Treatment
关键词
KI-67
反义寡核苷酸
KI-67标记指数
肝癌
Ki-67
Antisense oligodeoxyribonucleotides
Ki-67 labeling index
Hepatocellular carcinoma